In line with these findings, a recent study identifying AQP5 in SPEM glands and at the base of incomplete intestinal metaplasia glands demonstrates that AQP5 expression is under the control of IL-13, further reinforcing the concept that this cytokine plays a fundamental role in the development of metaplasia and possibly, its progression to cancer [64]. The gene discussed is AQP5; the disease is cancer.